Phase 1b/ 2 Study of a Radio-Enhancer, PEP503 (NBTXR3), in Combination with Concurrent Chemo-Radiation in Locally Advanced or Unresectable Rectal Cancer.
Journal of clinical oncology(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of clinical oncology(2022)